Top Markets
#1 Glidr Glidr +45.67%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#3 Movement Movement +9.79%
#4 Victoria VR Victoria VR +7.64%
#5 DMT-NAT DMT-NAT +7.02%
#6 Pons Pons +6.47%
#7 MarsCoin MarsCoin +5.30%
#8 Cryptopia Cryptopia +5.23%
#9 Lisk Lisk +5.01%
#10 Jito Jito +4.63%
Coin of the day
Glidr Glidr
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Rang in Aktien #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$7.87K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-50.00%
Land
US
Handel Biostax Corp. (BTAX)

Kategorie

Healthcare
Preis BTAX mit Marktkapitalisierung von B
Biostax Corp. Biostax Corp.
BTAX
$0.0001
Marktkapitalisierung von Biostax Corp.(BTAX)
Marktkapitalisierung: $7.87K
Mit Stand August 2026 hat Biostax Corp. eine Marktkapitalisierung von $7.87K. Das macht Biostax Corp. laut unseren Daten zum 41904th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Biostax Corp. von 2010 bis 2026
BTAX im Vergleich zu den Top 5 der beliebtesten stocks
Preis für BTAX Vermögenswert B Marktkapitalisierung von B Ergebnisse
Biostax Corp. Biostax Corp.
$68,394.86 $7.87K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.383T +68,394,860,273.52%
Biostax Corp. Biostax Corp.
$56,198.59 $7.87K
Apple Inc. Apple Inc.
AAPL
$4.423T +56,198,592,248.34%
Biostax Corp. Biostax Corp.
$52,856.94 $7.87K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +52,856,935,474.67%
Biostax Corp. Biostax Corp.
$46,542.00 $7.87K
Microsoft Corporation Microsoft Corporation
MSFT
$3.663T +46,542,000,115.98%
Biostax Corp. Biostax Corp.
$36,732.67 $7.87K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.891T +36,732,674,215.84%